Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Nilüfer Güler"'
Autor:
Çağlar Ünal, Tolga Özmen, Çetin Ordu, Kezban Nur Pilanci, Ahmet Serkan İlgün, Erhan Gökmen, Elvina Almuradova, Mustafa Özdoğan, Nilüfer Güler, Cihan Uras, Halil Kara, Orhan Demircan, Selver Işık, Gül Alço, Pınar Saip, Esra Aydın, Tomris Duymaz, Filiz Çelebi, Kanay Yararbaş, Gursel Soybir, Vahit Ozmen
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe Oncotype Dx recurrence score (ODx-RS) guides the adjuvant chemotherapy decision-making process for patients with early-stage hormone receptor-positive, HER-2 receptor-negative breast cancer. This study aimed to evaluate survival and its
Externí odkaz:
https://doaj.org/article/a5aa0615c47b4b81b959ce30fea9d08c
Publikováno v:
European Journal of Breast Health, Vol 10, Iss 3, Pp 184-188 (2014)
Externí odkaz:
https://doaj.org/article/cf47ccd0b86b459f9b8908cb3a8fea4f
Autor:
Nilüfer Güler, Bülent Karabulut, Mehmet Ali Koçdor, Handan Kaya, Gül Esen, Cihangir Özaslan, Pınar Saip, İlknur Görken
Publikováno v:
European Journal of Breast Health, Vol 7, Iss 2, Pp 68-89 (2011)
The definition of locally advanced breast cancer mainly describes the clinically stage III disease. The aim of neoadjuvant chemotherapy (NACT) is achieving the chance of applying breast-conserving surgery (BCS) in primary operable breast cancer; ensu
Externí odkaz:
https://doaj.org/article/8b582568d6624193b6fa45dc32ff7f30
Autor:
Pınar Saip, Serkan Keskin, Metin Özkan, Mehmet Ali Kaplan, Fatma Aydoğan, Güzin Gönüllü Demirağ, Sernaz Uzunoğlu, Hüseyin Engin, Gül Başaran, Nilüfer Güler, Kazım Uygun, Binnaz Demirkan, Feyyaz Özdemir, Erdem Çubukçu, Taflan Salepçi, İrfan Çiçin
Publikováno v:
European Journal of Breast Health, Vol 7, Iss 2, Pp 109-117 (2011)
Purpose:We aimed to determine the elapsed time between the first notification of the disease and the accession to the diagnosis and treatment modalities and its associated factors in female patients with breast cancer in Turkey.Patients and Methods:T
Externí odkaz:
https://doaj.org/article/9c88287d3f0748bda34bb4403a75c41c
Publikováno v:
European Journal of Breast Health, Vol 8, Iss 4, Pp 163-165 (2012)
Externí odkaz:
https://doaj.org/article/53e5dd9864c64cfbb40c7245e68f9911
Autor:
Atakan Demir, Nil Molinas Mandel, Semra Paydas, Gökhan Demir, Özlem Er, Nazım Serdal Turhal, Sevil Bavbek, Yeşim Eralp, Pınar Mualla Saip, Emine Nilüfer Güler, Adnan Aydıner, Başak Oyan Uluç, Sadettin Kılıçkap, Necdet Üskent, Nuri Karadurmuş, Mehmet Ali Kaplan, Mustafa Teoman Yanmaz, Hacer Demir, Özkan Alan, Taner Korkmaz, Polat Olgun, Özlem Sönmez Uysal, Kadri Altundağ, Şeyda Gündüz, Meral Günaldı, Murat Sarı, İsmail Beypınar, Gül Başaran
Publikováno v:
Balkan Medical Journal, Vol 37, Iss 2, Pp 104-107 (2020)
Background:The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen receptor-positive metastatic breast cancer. In spite of this, the activity of CDK4/6
Externí odkaz:
https://doaj.org/article/04ceb2349b6c44ffbafb27dfc640256d
Autor:
Atakan Demir, Nil Molinas Mandel, Semra Paydas, Gökhan Demir, Özlem Er, Nazım Serdal Turhal, Sevil Bavbek, Yeşim Eralp, Pınar Mualla Saip, Nilüfer Güler, Adnan Aydıner, Başak Oyan Uluç, Sadettin Kılıçkap, Necdet Üskent, Nuri Karadurmuş, Mehmet Ali Kaplan, Mustafa Teoman, Teoman Yanmaz, Hacer Demir, Özkan Alan, Taner Korkmaz, Polat Olgun, Özlem Sönmez Uysal, Kadri Altundağ, Şeyda Gündüz, Meral Günaldı, Murat Sarı, İsmail Beypınar, Gül Başaran
Publikováno v:
Balkan Medical Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecb0a8d37ecceb50170be1591f79a1bd
https://doi.org/10.4274/balkanmedj.galenos.2019.11.143
https://doi.org/10.4274/balkanmedj.galenos.2019.11.143
Autor:
Nilüfer Güler
Publikováno v:
Breast Disease ISBN: 9783030167912
Breast Disease ISBN: 9783319260105
Breast Disease ISBN: 9783319260105
Inflammatory breast carcinoma (IBC) is the most aggressive, lethal, and rare form of breast cancer. IBC is characterized by the rapid development of erythema, edema, and peau d’orange over a third or more of the skin of the breast due to the occlus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4c14212947a4c7c535375118a991a94
https://doi.org/10.1007/978-3-030-16792-9_16
https://doi.org/10.1007/978-3-030-16792-9_16
Autor:
Engin Ok, Burcu Çakar, Erhan Gokmen, Mustafa Ozdogan, Vahit Ozmen, Abdurrahman Isikdogan, Pinar Saip, Cihan Uras, Nilüfer Güler, Orhan Demircan
WOS: 000473357300009
PubMed ID: 31312795
Objective: Breast cancer is a heterogenous disease, and genetic profiling helps to individualize adjuvant treatment. The Oncotype DX is a validated test to predict benefit of adjuvant systemic treatm
PubMed ID: 31312795
Objective: Breast cancer is a heterogenous disease, and genetic profiling helps to individualize adjuvant treatment. The Oncotype DX is a validated test to predict benefit of adjuvant systemic treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df5cb5c50aa10563916878b800d4f843
https://hdl.handle.net/11454/28856
https://hdl.handle.net/11454/28856
Autor:
Nilüfer Güler
Publikováno v:
Breast Cancer ISBN: 9783319969466
Inflammatory breast carcinoma (IBC) is the most aggressive, lethal, and rare form of breast cancer and is characterized by the rapid development of erythema, edema, and peau d’orange over a third or more of the skin of the breast due to the occlusi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::558344a4ca71c4bbdd9b6d2bbc28a297
https://doi.org/10.1007/978-3-319-96947-3_11
https://doi.org/10.1007/978-3-319-96947-3_11